会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 2. 发明授权
    • Biphenyl vasopressin agonists
    • 联苯加压素激动剂
    • US07465722B2
    • 2008-12-16
    • US11502982
    • 2006-08-11
    • Amedeo A. FailliJohn P. DuszaThomas J. CaggianoJay S. ShumskyKevin A. MemoliEugene J. Trybulski
    • Amedeo A. FailliJohn P. DuszaThomas J. CaggianoJay S. ShumskyKevin A. MemoliEugene J. Trybulski
    • C07D487/02A61K31/551
    • C07D243/10C07D243/38C07D401/06C07D471/04C07D471/14C07D487/04C07D495/04
    • A compound of the formulae (I) or (II): wherein: Y is a moiety selected from NR or —(CH2)n; wherein R is hydrogen or (C1-C6) lower alkyl, and n is 1; represents: (1) a phenyl ring optionally substituted with one or two substituents selected, independently, from the group comprising hydrogen, (C1-C6) lower alkyl, halogen, cyano, CF3, hydroxy, (C1-C6) lower alkoxy, (C1-C6) lower alkoxy carbonyl, carboxy, —CONH2, —CONH[(C1-C6) lower alkyl], —CON[(C1-C6) lower alkyl]2; or(2) a 6-membered aromatic (unsaturated) heterocyclic ring having one nitrogen atom, optionally substituted by (C1-C6) lower alkyl, halogen or (C1-C6) lower alkoxy; represents: (1) a phenyl ring optionally substituted with one or two substituents selected, independently, from the group comprising hydrogen, (C1-C6) lower alkyl, halogen, cyano, CF3, hydroxy, (C1-C6) lower alkoxy, or (C1-C6) lower alkoxy carbonyl, carboxy, —CONH2, —CONH[(C1-C6) lower alkyl], —CON[(C1-C6) lower alkyl]2; or(2) a 5-membered aromatic (unsaturated) heterocyclic ring having one nitrogen atom, optionally substituted by (C1-C6) lower alkyl, (C1-C6) lower alkoxy, or halogen; or(3) a 6-membered aromatic (unsaturated) heterocyclic ring having one nitrogen atom, optionally substituted by (C1-C6) lower alkyl, halogen, or (C1-C6) lower alkoxy; represents a 5-membered aromatic (unsaturated) heterocyclic ring having one sulfur atom, optionally substituted by (C1-C6) lower alkyl, halogen, or (C1-C6) lower alkoxy; R1 is a moiety of the formula and R2, R3, R7, R8 and R9 are, independently, selected from a group consisting of hydrogen, (C1-C3) lower alkyl, OCH3, halogen, CF3, —SCH3, OCF3, SCF3, or CN; or a pharmaceutically acceptable salt, or pro-drug form thereof.
    • 式(I)或(II)的化合物:其中:Y是选自NR或 - (CH 2)n的部分; 其中R是氢或(C1-C6)低级烷基,n是1; (C1-C6)低级烷基,卤素,氰基,CF3,羟基,(C1-C6)低级烷氧基,(C1-C6)低级烷氧基,(C1-C6)低级烷氧基,(C1-C6) C 1 -C 6低级烷氧基羰基,羧基-CONH 2,-CONH [(C 1 -C 6)低级烷基],-CON [(C 1 -C 6)低级烷基] 或(2)任选被(C 1 -C 6)低级烷基,卤素或(C 1 -C 6)低级烷氧基取代的具有一个氮原子的6元芳族(不饱和)杂环; 表示:(1)任选被一个或两个取代基取代的苯环,所述取代基独立地选自氢,(C 1 -C 6)低级烷基,卤素,氰基,CF 3,羟基,(C 1 -C 6)低级烷氧基或 (C 1 -C 6)低级烷氧基羰基,羧基,-CONH 2,-CONH [(C 1 -C 6)低级烷基],-CON [(C 1 -C 6)低级烷基] 或(2)任选被(C 1 -C 6)低级烷基,(C 1 -C 6)低级烷氧基或卤素取代的具有一个氮原子的5元芳族(不饱和)杂环; 或(3)具有一个氮原子,任选被(C 1 -C 6)低级烷基,卤素或(C 1 -C 6)低级烷氧基取代的6元芳族(不饱和)杂环; 表示任选被(C 1 -C 6)低级烷基,卤素或(C 1 -C 6)低级烷氧基取代的具有一个硫原子的5元芳族(不饱和)杂环; R1是下式的部分,R2,R3,R7,R8和R9独立地选自氢,(C1-C3)低级烷基,OCH3,卤素,CF3,-SCH3,OCF3,SCF3, 或CN; 或其药学上可接受的盐或其前体药物形式。
    • 5. 发明授权
    • Substituted tetrahydro-pyrimidine-2(1H)-thione HDL-C elevators useful as antiatherosclerotic agents
    • 用作抗动脉粥样硬化剂的取代的四氢嘧啶-2(1H) - 硫酮HDL-C电梯
    • US06340687B1
    • 2002-01-22
    • US09145895
    • 1998-09-02
    • Amedeo A. FailliJay S. ShumskyKevin A. MemoliDonald P. Strike
    • Amedeo A. FailliJay S. ShumskyKevin A. MemoliDonald P. Strike
    • C07D23940
    • C07D239/10
    • Antiatherosclerotic agents are provided having the following structure: wherein: R1 is hydrogen, alkyl of 1-6 carbon atoms, cycloalkyl of 3-8 carbon atoms, alkenyl of 2-7 carbon atoms, alkynyl of 2-7 carbon atoms, or phenylalkyl of 7-10 carbon atoms; and R2, R3, R4, R5, and R6 are each, independently, hydrogen, halogen, alkyl of 1-6 carbon atoms, cycloalkyl of 3-8 carbon atoms, alkenyl of 2-7 carbon atoms, alkynyl of 2-7 carbon atoms, aralkyl of 7-10 carbon atoms, alkoxy of 1-6 carbon atoms, aryloxy of 6-12 carbon atoms, aralkyloxy of 7-12 carbon atoms, fluoroalkoxy of 1-6 carbon atoms, trifluoromethyl, alkylthio of 1-3 carbon atoms, alkylsulfonyl of 1-3 carbon atoms, —SCF3, nitro, alkylamino in which the alkylamino moiety has 1-6 carbon atoms, or dialkylamino in which each alkyl group has 1-6 carbon atoms; or a pharmaceutically acceptable salt thereof.
    • 提供具有以下结构的抗动脉粥样硬化剂:其中:R1是氢,1-6个碳原子的烷基,3-8个碳原子的环烷基,2-7个碳原子的链烯基,2-7个碳原子的炔基或苯基烷基 7-10个碳原子; 和R 2,R 3,R 4,R 5和R 6各自独立地为氢,卤素,1-6个碳原子的烷基,3-8个碳原子的环烷基,2-7个碳原子的烯基,2-7个碳原子的炔基 7-10个碳原子的芳烷基,1-6个碳原子的烷氧基,6-12个碳原子的芳氧基,7-12个碳原子的芳烷氧基,1-6个碳原子的氟烷氧基,三氟甲基,1-3个碳原子的烷硫基 ,1-3个碳原子的烷基磺酰基,-SCF 3,硝基,其中烷基氨基部分具有1-6个碳原子的烷基氨基,或每个烷基具有1-6个碳原子的二烷基氨基; 或其药学上可接受的盐。
    • 7. 发明授权
    • Arylthiophene vasopressin agonists
    • 芳基噻吩加压素激动剂
    • US06297234B1
    • 2001-10-02
    • US09495505
    • 2000-02-01
    • Amedeo A. FailliDavid K. WilliamsThomas J. CaggianoJay S. ShumskyMark A. Ashwell
    • Amedeo A. FailliDavid K. WilliamsThomas J. CaggianoJay S. ShumskyMark A. Ashwell
    • C07D40910
    • C07D471/04C07D487/04
    • The present invention provides compounds of the general formula: wherein Y is a moiety selected independently, from NH or —(CH2)n— wherein n is 1; m is an integer from 1 to 2; and the moiety represents: (1) a 5-membered aromatic (unsaturated) heterocyclic ring having one nitrogen (wherein A is nitrogen, and B and C are CH), (2) a 6-membered aromatic (unsaturated) heterocyclic ring having one nitrogen (wherein A is carbon, B is nitrogen, and C is —CH—CH—), (3) a 6-membered aromatic (unsaturated) ring (wherein A is carbon, B is CH, and C is —CH—CH—); as well as methods and pharmaceutical compositions utilizing these compounds for the treatment of disorder which may be remedied or alleviated by vasopressin agonist activity, including diabetes insipidus, nocturnal enuresis, nocturia, urinary incontinence, bleeding and coagulation disorders, or temporary delay of urination.
    • 本发明提供以下通式的化合物:其中Y是独立地选自NH或 - (CH 2)n - 其中n为1的部分; m为1〜2的整数; 并且该部分表示:(1)具有一个氮的5元芳族(不饱和的)杂环(其中A是氮,B和C是CH),(2)具有一个氮的6元芳族(不饱和的)杂环 (其中A为碳,B为氮,C为-CH-CH-),(3)6元芳族(不饱和的)环(其中A为碳,B为CH,C为-CH-CH- ); 以及利用这些化合物治疗可通过加压素激动剂活性(包括尿崩症,夜间遗尿症,夜尿症,尿失禁,出血和凝血障碍)或临时排尿延迟而加以补救或减轻的病症的方法和药物组合物。
    • 8. 发明授权
    • 1H-pyrido[2,3-b][1,5]benzodiazipine vasopressin agonists
    • 1H-吡啶并[2,3-b] [1,5]苯并二氮嗪加压素激动剂
    • US06268360B1
    • 2001-07-31
    • US09698725
    • 2000-10-27
    • Amedeo A. FailliDavid K. WilliamsThomas J. CaggianoJay S. ShumskyMark A. Ashwell
    • Amedeo A. FailliDavid K. WilliamsThomas J. CaggianoJay S. ShumskyMark A. Ashwell
    • C07D40910
    • C07D471/04C07D487/04
    • The present invention provides compounds of the general formula: wherein Y is a moiety selected independently, from NH or —(CH2)n— wherein n is 1; m is an integer from 1 to 2; and the moiety represents: (1) a 5-membered aromatic (unsaturated) heterocyclic ring having one nitrogen (wherein A is nitrogen, and B and C are CH), (2) a 6-membered aromatic (unsaturated) heterocyclic ring having one nitrogen (wherein A is carbon, B is nitrogen, and C is —CH—CH—), (3) a 6-membered aromatic (unsaturated) ring (wherein A is carbon, B is CH, and C is —CH—CH—); as well as methods and pharmaceutical compositions utilizing these compounds for the treatment of disorder which may be remedied or alleviated by vasopressin agonist activity, including diabetes insipidus, nocturnal enuresis, nocturia, urinary incontinence, bleeding and coagulation disorders, or temporary delay of urination.
    • 本发明提供以下通式的化合物:其中Y是独立地选自NH或 - (CH 2)n - 其中n为1的部分; m为1〜2的整数; 并且该部分表示:(1)具有一个氮的5元芳族(不饱和的)杂环(其中A是氮,B和C是CH),(2)具有一个氮的6元芳族(不饱和的)杂环 (其中A为碳,B为氮,C为-CH-CH-),(3)6元芳族(不饱和的)环(其中A为碳,B为CH,C为-CH-CH- ); 以及利用这些化合物治疗可通过加压素激动剂活性(包括尿崩症,夜尿,夜尿,尿失禁,出血和凝血障碍)或临时排尿延迟而补救或缓解的病症的方法和药物组合物。